InvestorsHub Logo
icon url

TZOR

08/04/15 7:53 PM

#38063 RE: laser777 #38061

That would depend on the terms. I don't think announcing a partnership would mean a doubling of sp (I hope it would). It would add to validity claims, there is a partnership because so&so thinks DCVax works. Shorts would then point to something about the partnership as a negative, it's what they do. If we had a partnership agreement like Celgene with Juno, that would cease any cash problems. If we had that we could see a doubling of sp, but more likely a 25-50% increase. Here's to hoping we get some positive news soon.
icon url

beachlifeisfun

08/04/15 7:58 PM

#38065 RE: laser777 #38061

No, I think that it would be smarter for them to partner with BP for a single, high profile indication and keep the rest for themselves. This would give them credibility in the market, with doctors, and provide the capital they need to finish the job on other indications. We are talking about, arguably, a cure for the most prevalent, most diverse disease of all of man and animal...with minimal side effects...NWBO is currently the frontrunner to supply a drug to "cure" all inoperable and operable solid tumors...there is plenty of pie to go around. JMHO